期刊文献+

10000例宫颈液基细胞学结果分析 被引量:3

An analysis on the results of thinprep liquid based cytological test in 10 000 patients
下载PDF
导出
摘要 目的对2011年我院10000例宫颈液基细胞学(TCT)的检测结果进行分析,并将TCT与组织病理结果进行对比,评价TCT在宫颈病变诊断中的价值。方法对10000例TCT标本应用TBS分级系统进行分析,其中诊断意义不明的不典型鳞状上皮细胞(ASCUS)及以上病变定义为阳性,对其中行活检的患者,以病理结果为金标准,将TCT结果与病理活检结果进行对比分析。结果10000例受检标本中,不合格标本8例(0.8%。),阳性结果为561例(5.61%),其中ASC—H18例,ASCUS333例,LSIL164例,HSIL44例,癌1例,AGC—N1例。宫颈细胞学异常高发人群集中在20—50岁,其中ASCUS和LSIL主要发生在20~40岁,ASC—H和HSIL主要集中在30—50岁。与病理活检结果对比,LSIL符合率为71.6%,HSIL符合率为77.8%。结论宫颈上皮病变有年轻化的趋势,TCT诊断和活检结果符合率较高,TCT是宫颈上皮内病变筛查的最为重要的手段之一。 Objective By analying 10 000 thinprep liquid based cytological test (TCT) results, we assessed the value of TCT in the diagnosis of cervical disease; and then we explored the rate of concordance between positive cervical cytological interpretation based on liquid-based preparations and subsequent histological diagnosis. Methods The diagnosis of 10 000 patients was made according to the criteria of Bethesda system (TBS), and then compared with the TCT results and the histological diagnosis in the patients with positive results. Results Of the 10 000 patients, 561 (5.61%) were abnormal including 18 ASC-H,333 ASCUS, 164 LSIL, 44 HSIL, one cancer, and one AGC - N. The high-risk of cervical cytology focused on twenty to fifty years, with ASCUS and LSIL mainly in the twenty -years old, ASC - H and HSIL mainly concentrated in the thirty to fifty years old. By comparing with histological diagnosis, LSIL coincidence rate was 71.6% and HSIL was 77.8%. Conclusions Cervical epithelial lesions have a trend in younger people. TCT has a high agreement with biopsy in positive rate, which suggests that TCT has certain predicative value for pathological results.
出处 《国际医药卫生导报》 2013年第15期2336-2339,共4页 International Medicine and Health Guidance News
关键词 宫颈液基细胞学 组织活检病理 符合率 Thinprep liquid based cytological test Histological diagnosis Coincidence rate
  • 相关文献

参考文献9

  • 1Peto J, Gilham C, Fletcher O, et al. The cervical cancer epidemic that screening has prevented in the UK[J]. Lancet, 2004, 364(9430): 249-256.
  • 2Bentz JS. Liquid-based cytology for cervical cancer screening[J]. Expert review of molecular diagnostics, 2005, 5(6): 857-871.
  • 3Bigras G, Rieder MA, Lambercy JM, et al. Keeping collecting device in liquid medium is mandatory to ensure optimized liquid-based cervical cytologic sampling[J]. J Low Genit Tract Dis, 2003, 7(3): 168-174.
  • 4郎景和.子宫颈上皮内瘤变的诊断与治疗[J].中华妇产科杂志,2001,36(5):261-263. 被引量:1252
  • 5陈黎萍,王娟.巴氏涂片与液基细胞学应用于宫颈病变筛查的临床比较分析[J].检验医学与临床,2012,9(1):126-127. 被引量:13
  • 6殷秀琴,王小菊,赵俊英,刘岩.液基细胞学检测及阴道镜检查诊断宫颈病变的临床意义[J].首都医科大学学报,2007,28(5):658-660. 被引量:18
  • 7Mathew A, George PS. Trends in incidence and mortality rates of squamous cell carcinoma and adenocarcinoma of cervix-worldwide[J]. Asian Pac J Cancer Prev, 2009, 10(4): 645-650.
  • 8Behtash N, Mehrdad N. Cervical cancer: screening and prevention[J]. AsianPacJCaneerPrev, 2006, 7(4): 683-686.
  • 9Saslow D, Runowicz CD, Solomon D, et al. American Cancer Society guideline for the early detection of cervical neoplasia and cancer[J]. CA Cancer J Clin, 2002, 52(6): 342-362.

二级参考文献14

共引文献1279

同被引文献26

  • 1张贺,刘富荣,李萍,高红容,王霞.不同宫颈筛查方案在临床应用中的价值分析[J].实用癌症杂志,2014,29(3):278-280. 被引量:9
  • 2杜茜,邓永丽,张全,袁艺.人乳头瘤病毒在宫颈癌前病变诊断中的意义[J].解放军医学杂志,2006,31(5):462-464. 被引量:6
  • 3Syrialen S, Shabalova IP, Petrovichev N, et al. Human papillomavirus tsting and conventional Pap smea cytology as optiona 1 SCreening tools of women at different risks for cervical cancer in Countries of the form er Sovietnion[J]. JLow Genit Tract Dis, 2002, 6(!0): 97-110.
  • 4Bosch FX, Manos MM, Munoz N,. et al. Preyalence of human papillomavirus in cervical cneer : a world wide perspective. Internationa biological study oncervical cancer(IBScC )Study Group[J]. J Natl CancerInst,1995, 87 (16) : 796 -802.
  • 5Ferris Dq Cox TJ. Modem colposeopy: textbook and atlas,[Ml; 2nd ed. USA : Kendal/hunt publishing Comoanv, 2004 : 144 -483.
  • 6Blumenthal PD, Gafikin L, Chirenje ZM, et al. Adju,.nctive testingfor cervical cancer in low resource settings w!lh visual in spection, HPV and the Papsmear[J]. nt J Gyraecol Obstet, 2001, 72 (12) : 47--53.
  • 7Tjalma WA. The ideal cervical cancer screening recom- mendation for Belgium,an industrialized country in Eu- rope[J]. Eur J Gynaecol Oncol, 2014,35(3) : 211-218.
  • 8Wang Y,Yu YH,Shen K, et al. Cervical cancer screening and analysis of potential risk factors in 43,567 women in Zhongshan,China[J]. Asian Pac J Cancer Prev,2014,15(2): 671-676.
  • 9Laowahutanont P,Karalak A,Wongsena M,et al. Preva- lence of high risk human papillomavirus infection with different cervical cytological features among women un- dergoing health examination at the National Cancer Insti- tute,Thailand[J]. Asian Pac J Cancer Prev,2014,15(14): 5879-5882.
  • 10Moosa NY,Khattak N,Alam MI,et al. Comparison of cervical cell morphology using two different cytology tech- niques for early detection of pre-cancerous lesions[J]. Asian Pac J Cancer Prey, 2014,15(2) : 975-981.

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部